BiotechTube
Intact Therapeutics

Intact Therapeutics

San Diego, United States· Est.
intacttherapeutics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $5M

Overview

Intact Therapeutics is a private, clinical-stage biotech company based in San Diego, founded in 2018. It has pivoted from an initial focus on oncology and immunology to now specialize in developing localized drug delivery technologies for gastrointestinal diseases. The company is in the early stages of clinical development, positioning itself to tackle significant unmet needs in the GI therapeutic space with a patient-centric mission. Key details regarding its pipeline, leadership team, and financial backing are not publicly disclosed on its minimal website.

Gastrointestinal Disease

Technology Platform

Proprietary platform for next-generation localized drug delivery technologies targeting the gastrointestinal tract.

Funding History

2
Total raised:$5M
Grant$2M
Seed$3M

Opportunities

The large and growing market for gastrointestinal therapeutics, particularly in areas like inflammatory bowel disease, presents a significant opportunity.
A successful localized delivery platform could offer superior safety and efficacy profiles compared to systemic therapies, addressing a major unmet need and capturing substantial market share.

Risk Factors

The company faces high clinical risk with an unproven platform, severe financial risk as a pre-revenue entity dependent on external funding, and intense competition in the GI space.
The complete lack of public information on pipeline, leadership, and finances adds substantial uncertainty and perception risk.

Competitive Landscape

The GI therapeutics market is highly competitive, dominated by large pharma companies and numerous biotechs developing both systemic and localized treatments. Intact will need to demonstrate clear differentiation in efficacy, safety, or convenience to succeed against established and emerging therapies.

More companies in Small Molecule Drugs →More companies in United States →